A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.

Authors

Robert W Buchanan
Deanna L Kelly
Elaine Weiner
James M Gold
Gregory P Strauss
Maju M Koola, George Washington UniversityFollow
Robert P McMahon
William T Carpenter

Document Type

Journal Article

Publication Date

6-5-2017

Journal

Journal of Clinical Psychopharmacology

DOI

10.1097/JCP.0000000000000720

APA Citation

Buchanan, R., Kelly, D., Weiner, E., Gold, J., Strauss, G., Koola, M., McMahon, R., & Carpenter, W. (2017). A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.. Journal of Clinical Psychopharmacology, (). http://dx.doi.org/10.1097/JCP.0000000000000720

Peer Reviewed

1